Healthcare investment in the Gulf has long centred on hospitals, imported drugs, and Western operating models, with most technology bought in from abroad. PitchBook data shows GCC healthtech startups raised US$148 million in disclosed funding between January 2025 and July 2026, and investors heading to WHX Tech in Dubai say the next task is financing those companies beyond their first rounds.

[For more news, click here]

In recent years, the Gulf’s approach to healthcare technology followed a familiar pattern in which governments and hospital groups built large, modern facilities, imported the equipment and software to run them, and licensed operating models proven in the United States and Europe. The region was a large and reliable customer for healthcare innovation, but rarely its source.

Although new data comes from a modest base, it suggests that pattern is starting to change. Healthtech startups across the Gulf Cooperation Council attracted US$148 million in disclosed funding between January 2025 and July 2026, according to PitchBook data released ahead of WHX Tech, the digital health event running from 26 to 28 January 2027 at Dubai World Trade Centre. The figures cover 32 funded companies across five GCC markets.

Where Is GCC Healthtech Investment Going?

Saudi Arabia accounts for the largest share of that activity, with 17 of the 32 funded companies, followed by the United Arab Emirates with 11. The remaining four are spread across three other Gulf markets. Deal flow held steady through the period, with 21 transactions closing in 2025 and a further 11 in the first half of 2026, concentrated in digital health, telehealth, women’s health, and AI-driven diagnostics.

To put the market to scale, it can be pictured alongside the United States where, according to Rock Health, US digital health startups raised US$7.4 billion across 244 deals in the first half of 2026 alone, with a median deal size of US$14 million. The two datasets use different methodologies, but the comparison puts the regional figure in perspective. The GCC’s 32 funded companies raised an average of under US$5 million each over 19 months, which points to a market still dominated by early-stage rounds.

From Healthcare Buyer to Builder

“What excites me is that the GCC is starting to move from being a buyer of healthcare innovation to actually wanting to build it. Historically, healthcare investment in the region focused on hospitals, healthcare delivery, drug imports, or the introduction of existing Western business models into the Middle East. That’s changing quite quickly,” said Tugce Ergul, Founding Partner of Hypernova Capital and a member of the WHX Tech Investor Programme, who sees the shift as structural rather than cyclical.

Ergul, who is based in San Francisco, points to Abu Dhabi’s growing capabilities in genomics, precision medicine, clinical research, and health data, alongside Saudi Arabia’s ambitions in vaccines, biologics manufacturing, and pharmaceutical localisation. Both efforts draw on long-term capital and on governments, regulators, health systems, and research institutions that are increasingly working together.

“In biotech, that matters a lot. Capital alone doesn’t build an ecosystem. You need patients, data, labs, regulators, manufacturing and researchers around the same table. That’s why I think the GCC is becoming much more interesting scientifically, not just financially,” Ergul added.

Rather than funding companies that digitise existing hospital processes, a growing share of interest is directed at using AI to generate new biological insights, improve prediction, and speed up scientific discovery. BioTwin, a Canadian digital health startup that is part of Abu Dhabi’s Hub71 ecosystem and one of the companies set to feature in WHX Tech’s Xcelerate Startup Competition, illustrates the model. The company is piloting virtual human twin technology with Cleveland Clinic Abu Dhabi, building individual patient profiles for breast cancer screening under a partnership first announced at Arab Health 2025.

Why Speed Draws North American Founders to the Gulf

Danielle Brewin Graham, General Partner of Phoenix Fire Ventures, Co-Founder of The Firehood, and a WHX Tech advisory board member stated: “The region’s advantage is speed. Regulatory sandboxes and government-backed programmes let healthtech founders pilot with real institutional partners far faster than in North America, where pilots can take years to unlock. The opportunity is for founders who build solutions designed for rapid deployment across a young, digitally fluent, multi-market population spanning the GCC.”

Faster access does not remove the commercial hurdles, in fact, investors expect healthtech companies to demonstrate clinical relevance, regulatory readiness, and a credible route to scale, and expanding across the Gulf requires founders to work through distinct regulatory and cultural environments in each market while building early relationships with government, healthcare, and institutional stakeholders.

Brewin Graham also identifies a structural weakness that could limit how far the current cohort of startups can grow.

“The biggest gap is usually mid-stage capital and mentorship density. There’s often strong early-stage enthusiasm and government support, but a thinner bench of experienced operators who’ve scaled a company through Series A and beyond and can mentor the next cohort. Platforms that import that operational experience, and pair it with local capital and government relationships, close that gap fastest,” said Graham.

What WHX Tech 2027 Brings to Dubai

WHX Tech’s Investor Programme and Xcelerate Startup Competition, held on the event’s Xcelerate Stage, are designed to connect early-stage healthtech companies with investors, healthcare decision-makers, and potential partners. The event forms part of World Healthcare Week, which runs alongside World Health Expo and WHX Leaders across Dubai Exhibition Centre at Expo City and Dubai World Trade Centre from 25 to 28 January 2027. Organiser Informa Markets expects more than 5,000 digital health professionals, over 200 brands, and 200 speakers from more than 30 countries at WHX Tech.

“The technology transforming healthcare is increasingly being developed at the intersection of different disciplines, from AI and biological data to diagnostics, digital platforms and connected care. WHX Tech is designed to put that technology in front of the people who can help take it further: investors, healthcare decision-makers, technology partners and policymakers. We want to demonstrate where technology is already addressing real healthcare challenges, while giving founders the connections they need to move from innovation to adoption and scale,” said Lorena Diaz Palle, Event Director, WHX Tech.

Related Articles

Saudi MedTech 2026 to Bring Global Health Tech Leaders to Riyadh

How 1001 Raised $30 Million to Bring Sovereign AI to Ports, Airports and Energy Grids

Dubai Consolidates a Decade of Founder Support Into One Hub, Then Opens a New Door for First-Time Entrepreneurs